Romesh Subramanian's most recent trade in Dyne Therapeutics Inc was a trade of 128,185 Stock Option (right to buy) done . Disclosure was reported to the exchange on Sept. 16, 2020.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dyne Therapeutics Inc | Romesh Subramanian | Chief Scientific Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2020 | 128,185 | 128,185 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Romesh Subramanian | Chief Scientific Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2020 | 41,309 | 566,249 | - | 0 | Common Stock |